Phosphorylation of β-d-Ribosylbenzimidazoles Is Not Required for Activity against Human Cytomegalovirus

We have previously reported that 2,5,6-trichloro-1-(β-d-ribofuranosyl)benzimidazole (TCRB) and its 2-bromo analog (2-bromo-5,6-dichloro-1-(β-d-ribofuranosy)benzimidazole [BDCRB]) are potent and selective inhibitors of human cytomegalovirus (HCMV) replication that block viral DNA maturation via HCMV...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Krosky, Paula M., Borysko, Katherine Z., Nassiri, M. Reza, Devivar, Rodrigo V., Ptak, Roger G., Davis, Michelle G., Biron, Karen K., Townsend, Leroy B., Drach, John C.
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 2002
Témata:	Antiviral Agents
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127035/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11796361/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.2.478-486.2002
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!